Dr. Reddys Laboratories turns black in Q3 on consolidated basis

01 Feb 2021 Evaluate

Dr. Reddys Laboratories has reported results for third quarter ended December 31, 2020.

The company has reported 14.95% fall in its net profit at Rs 443.70 crore for the quarter under review as compared to net profit at Rs 521.70 crore for the same quarter in the previous year. However, total income of the company increased by 11.49% at Rs 3471.00 crore for Q3FY21 as compared Rs 3113.30 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported net profit of associate at Rs 27.90 crore for the quarter under review as compared to net loss at Rs 538.40 crore for the same quarter in the previous year. Total income of the company increased by 12.27% at Rs 5012.40 crore for Q3FY21 as compared Rs 4464.40 crore for the corresponding quarter previous year.

Dr. Reddys Lab Share Price

1190.35 -25.30 (-2.08%)
13-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.80
Dr. Reddys Lab 1190.35
Cipla 1447.60
Zydus Lifesciences 900.25
Lupin 2176.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×